MAPT and Cognitive impairment: Additionally, tau imaging may provide insights into the progression of neurodegenerative diseases, as the extent and location of tau deposition correlate with disease severity and cognitive impairment, offering a potential tool for tracking disease progression and evaluating therapeutic efficacy [28].